Starpharma Holdings Limited

Type: Company
Name: Starpharma Holdings Limited (STARPHARMA HOLDINGS LIMITED)
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Starpharma secures expanded deal with AstraZeneca

Starpharma (ASX:SPL) has revealed that AstraZeneca is evaluating using its dendrimer nanotechnology platform for a second oncology drug.AstraZeneca is evaluating incorporating Starpharma’s DEP dendrimer drug delivery technology into one of the cancer ... [Published Australian Life Scientist - Apr 14 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 3 reports

AstraZeneca expands StarPharma deal for cancer drug delivery tech

DEP delivery tech--Courtesy of StarPharmaAstraZeneca ( $AZN ) has expanded its deal with Australia's StarPharma , originally inked in September 2012, to use its drug delivery technology with a cancer drug in AstraZeneca's pipeline, according to a release. ... [Published Fierce Drug Delivery - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Biotechs are the new miners

This column has often said that listed biotechnology companies are the new miners as far as speculative bang for your buck is concerned, and Sirtex Medical, which has almost tripled since we first tipped it, is certainly evidence of that.We recently interviewed ... [Published Melbourne Age - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

STARPHARMA : expands its Drug Delivery Program with AstraZeneca

Starpharma expands its Drug Delivery Program with AstraZeneca Melbourne, Australia; 7 April 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced the signing of a second, expanded agreement with AstraZeneca in the field of cancer medicine ... [Published 4 Traders - Apr 08 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 9 reports

Starpharma Holdings Ltd Partners With Bio-Pharmaceutical Giant AstraZeneca PLC To Improve Cancer Treatment

Starpharma Holdings (ASX: SPL, OTCQX: SPHRY) has signed a second, expanded agreement with AstraZeneca (NYSE: AZN) in the field of cancer medicine using Starpharma’s proprietary DEP™ dendrimer drug delivery technology. The agreement follows on from an ... [Published BioSpace - Apr 08 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Your instant 7-share high-growth portfolio

A share portfolio for a serious investor should be well planned and thought out. For example an older investor nearing retirement age should switch to a defensive portfolio that invests in established, low-risk, dividend-paying companies.Below are seven ... [Published Motley Fool - Mar 21 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

Starpharma's VivaGel condoms approved in Japan

Starpharma ’s (ASX:SPL) Japanese licensee Okamoto Industries has secured approval to market VivaGel-coated condoms in the nation.Starpharma has granted Okamoto an exclusive commercial licence to market VivaGel-coated condoms in Japan.Under the terms of ... [Published Australian Life Scientist - Mar 17 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 1 reports

SPL - STARPHARMA HOLDINGS LIMITED

- 11:01AMStarpharma to present to US institutional investors February 27, 2014 - 03:26PMStarpharma Interim Report and Half-year Financial Results February 24, 2014 - 01:20PMStock WatchPatties Foods, the market leader in the savoury and fruit pie categories, ... [Published Canberra Times - Mar 14 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 2 reports

Aussie Startup, Japan Pharma Join To Launch First Antiviral Condom

Related Biotechnology, Pharmaceutical and Healthcare NewsAn Australia startup biotech, Starpharma, is readying for a launch of its first product in Japan later this year when a gel it and Okamoto developed becomes available in a $500 million condom m ... [Published BioPortfolio - Mar 14 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 3 reports

Stockwatch Week to March 14

A round-up of some of the key stock movements on the Australian Stock Exchange (ASX) in the trading week to Friday, March 14, 2014:ABC - ADELAIDE BRIGHTON - down 60 cents, or 13.8 per cent, at $3.75Construction materials supplier Adelaide Brighton warned ... [Published TheBull.com.au - Mar 14 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 4 reports

Starpharma offers rare bright spot in market

Starpharma Holdings (SPL) has finally delivered some much needed relief and shareholders will be hoping that today’s regulatory approval of its gel-coated condoms will break the stock out of its downtrend.It seems to be working for now, with the stock ... [Published Eureka Report - Mar 14 2014]
First reported Jan 24 2014 - Updated Jan 24 2014 - 1 reports

Starpharma starts Phase I clinical trial of dendrimer-docetaxel

Australia-based Starpharma has received necessary approvals to start a Phase I human clinical trial for its dendrimer-enhanced docetaxel (Taxotere) chemotherapeutic product, referred to as DEP-Docetaxel.Initially, the trial will be carried out in Australia, ... [Published Pharmaceutical Business Review - Jan 24 2014]

Quotes

In a final dig at mining explorers, Marais says that "unlike miners, which don't have a massive mining boom helping them any longer, you can do a lot of verification of the fundamentals underlying these biotechs, like their performance in clinical trials and their regulatory approvals."
Following this initial VivaGel ® ‐coated condom certification, Mr Takeuchi said, "We are very pleased to be in a partnership with Starpharma for this product."
"It also means that we and our shareholders do not need to invest inin all of the commercial opportunities to which our technology is applied" Dr Fairley said on Monday
Mr Fladrich added, "Australia is rich with innovative, discovery led companies in life sciences. However, to fully exploit the potential of this knowledge based sector we need policies that create an environment that encourages investment and will allow this sector to compete in what is a highly competitive global market place."

More Content

All (39) | News (36) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Starpharma secures expanded deal with AstraZeneca [Published Australian Life Scientist - Apr 14 2014]
Should you avoid these heavily shorted sectors ... [Published Motley Fool - Apr 14 2014]
AstraZeneca expands StarPharma deal for cancer ... [Published Fierce Drug Delivery - Apr 08 2014]
Biotechs are the new miners [Published Melbourne Age - Apr 08 2014]
STARPHARMA : expands its Drug Delivery Program ... [Published 4 Traders - Apr 08 2014]
STARPHARMA : VivaGel®-coated condom approved fo... [Published 4 Traders - Apr 08 2014]
Starpharma expands its Drug Delivery Program wi... [Published Noodls - Apr 08 2014]
Starpharma tech applied to AstraZeneca cancer drug [Published LabOnline - Apr 08 2014]
Starpharma Holdings Ltd Partners With Bio-Pharm... [Published BioSpace - Apr 08 2014]
Starpharma expands accord with AstraZeneca [Published BioPortfolio - Apr 07 2014]
Starpharma expands accord with AstraZeneca [Published Pharma Letter - Apr 07 2014]
Starpharma expands its Drug Delivery Program wi... [Published Star Pharma - Apr 07 2014]
Australia’s Starpharma extends deal with AstraZ... [Published Invezz - Apr 07 2014]
ASTRAZENECA : Starpharma expands its Drug Deliv... [Published 4 Traders - Apr 07 2014]
Starpharma extends AstraZeneca deal [Published Herald Sun - Apr 07 2014]
Starpharma extends AstraZeneca deal [Published NineMSN Finance - Apr 07 2014]
AstraZeneca to integrate dendrimer drug deliver... [Published Bio Spectrum Asia - Apr 07 2014]
Starpharma Holdings expands drug delivery progr... [Published Proactive Investors Australia - Apr 07 2014]
Your instant 7-share high-growth portfolio [Published Motley Fool - Mar 21 2014]
Benitec Biopharma Limited - Product Pipeline Re... [Published SBWire - Mar 21 2014]
Starpharma's VivaGel condoms approved in Japan [Published Australian Life Scientist - Mar 17 2014]
Pessimism takes hold as ASX crumbles [Published Motley Fool - Mar 16 2014]
SPL - STARPHARMA HOLDINGS LIMITED [Published Canberra Times - Mar 14 2014]
VivaGel®-coated condom approved for marketing i... [Published Star Pharma - Mar 14 2014]
Aussie Startup, Japan Pharma Join To Launch Fir... [Published BioPortfolio - Mar 14 2014]
Aussie Startup, Japan Pharma Join To Launch Fir... [Published Health News Daily - Mar 14 2014]
Stockwatch Week to March 14 [Published TheBull.com.au - Mar 14 2014]
Stocks to watch at close on Friday [Published Brisbane Courier-Mail - Mar 14 2014]
Starpharma offers rare bright spot in market [Published Eureka Report - Mar 14 2014]
Aussie biotech's super condoms get green light ... [Published Brisbane Times - Mar 14 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.